GM Watch
  • Main Menu
    • Home
    • News
      • Newsletter subscription
      • News Reviews
      • News Languages
        • Notícias em Português
        • Nieuws in het Nederlands
        • Nachrichten in Deutsch
      • Archive
    • Articles
      • GM Myth Makers
      • GM Reports
      • GM Quotes
      • GM Myths
      • Non-GM successes
      • GM Firms
        • Monsanto: a history
        • Monsanto: resources
        • Bayer: a history
        • Bayer: resources
    • Videos
      • Latest Videos
      • Must see videos
      • Agriculture videos
      • Labeling videos
      • Animals videos
      • Corporations videos
      • Corporate takeover videos
      • Contamination videos
      • Latin America videos
      • India videos
      • Asia videos
      • Food safety videos
      • Songs videos
      • Protests videos
      • Biofuel myths videos
      • Index of GM crops and foods
      • Index of speakers
      • Health Effects
    • Contact
    • About
    • Donations
News and comment on genetically modified foods and their associated pesticides    
  • News
    • Newsletter subscription
    • News Reviews
    • News Languages
      • Notícias em Português
      • Nieuws in het Nederlands
      • Nachrichten in Deutsch
    • Archive
      • 2022 articles
  • Articles
    • GM Myth Makers
    • GM Reports
    • GM Quotes
    • GM Myths
    • Non-GM successes
    • GM Firms
      • Monsanto: a history
      • Monsanto: resources
      • Bayer: a history
      • Bayer: resources
  • Donations
  • Videos
    • Index of speakers
    • Glyphosate Videos
    • Latest Videos
    • Must see videos
    • Health Effects
    • Agriculture videos
    • Labeling videos
    • Animals videos
    • Corporations videos
    • Corporate takeover videos
    • Contamination videos
    • Latin America videos
    • India videos
    • Asia videos
    • Food safety videos
    • Songs videos
    • Protests videos
    • Biofuel myths videos
    • Index of GM crops and foods
  • Contact
  • About

GMWatch Facebook cornfield banner

INTRODUCTION TO GM

GMO Myths and Facts front page.jpg

SCIENCE SUPPORTS REGULATION OF GENE EDITING

Plant tissue cultures

GENE EDITING: UNEXPECTED OUTCOMES AND RISKS

Damaged DNA on fire

GENE EDITING MYTHS AND REALITY

A guide through the smokescreen

Gene Editing Myths and Reality

ON-TARGET EFFECTS OF GENE EDITING

Damaged DNA

CITIZENS’ GUIDE TO GM

GMO Myths and Truths front cover

LATEST VIDEOS

  • Herbicide-tolerant/Bt cotton chaos in Indian fields
  • Seed keepers and truth tellers: From the frontlines of GM agriculture
  • Myths and Truths of Gene-Edited Foods

KEVIN FOLTA: A rogue’s gallery

Roundup, dollars and Kevin Folta

Please support GMWatch

Donations

You can donate via Paypal or credit/debit card.

Some of you have opted to give a regular donation. This is greatly appreciated as it helps place us on a more stable financial basis. Thank you for your support!

GMO-using fake meat company Impossible Foods' EU patent revoked

Details
Published: 01 February 2023
Twitter

Patent Revoked

Company's US patents are now being challenged. Report: Claire Robinson

The European Patent Office (EPO) has revoked an EU patent held by Impossible Foods, maker of the Impossible Burger. In the US, Impossible's fake meat products are manufactured with GMO yeast-derived soy leghemoglobin, a controversial ingredient that makes the fake meat look as if it's bleeding, like undercooked real meat, and that we have argued may not be safe to eat.

Following the EPO's decision, another fake meat company, Motif FoodWorks, has filed a suite of new petitions with the US Patent and Trademark Office challenging US patents held by Impossible Foods over the use of heme proteins (such as that present in soy leghemoglobin) in meat alternatives, as it defends itself against Impossible's accusations of patent infringement, according to Food Navigator USA.

Fake meat industry "a flop"

The news about Impossible's patent fights comes in the wake of an article by Bloomberg describing the rapid decline in the fake meat industry, which it branded "a flop". The article is titled, "Fake meat was supposed to save the world. It became just another fad".

Impossible shares, the article said, are currently trading at around $12 – about half the price during its last fundraising round. And more recently Bloomberg has reported that Impossible is preparing to lay off about 20% of its staff, following another round of cuts in October when about 6% of its staff got laid off.

The latest patent wars will only add to the industry's woes.

Impossible patents

Motif FoodWorks said that many of the claimed inventions in Impossible's patents are obvious and already disclosed in prior art, which means they cannot be patented. Motif added that the EPO's decision to revoke Impossible's patent "affirms our belief that Impossible's patents are invalid and never should have been issued in the first place".

Impossible Foods told Food Navigator USA that its plans to launch its full range of products in the EU have not changed. Its soy leghemoglobin "fake blood" product is currently being evaluated for EU use by the European Food Safety Authority (EFSA).

The EPO-revoked patent is not on soy leghemoglobin itself. It is a broad patent on food products containing iron complexes such as heme-containing proteins, combined with flavour precursor molecules.

Twisted logic

The EPO's reasoning has not yet been published online, but GMWatch has long argued that GMO developers cannot tell patent offices that their product is novel, non-obvious, and has an inventive step – all requirements for a patented invention – yet tell regulators and the public that the same product is natural, nature-mimicking, or able to arise in nature or from natural breeding. The GMO developers can't have it both ways; if one of these statements is true, the other must be false. If it's patented, it can't be natural, and if it's natural, it can't be patented.

The UK government is currently deregulating a subclass of GMOs that it claims could have arisen through "traditional processes". Earlier drafts used the wording "natural processes", but government amendments changed "natural" to "traditional". It is possible that the change of wording is intended to avoid GMO developers running into difficulties with patent offices over whether their products are genuine inventions.

The opposition to the EU patent, filed by the law firm Reiser & Partner Patentwälte mbB in Germany, alleges that Impossible's claimed invention is not novel, lacks an inventive step, fails to sufficiently describe the invention, and extends beyond the application as originally filed.

However, a spokesman for Impossible Foods told Food Navigator USA that the EPO's decision was not made on the basis of lack of novelty and that the review compared Impossible's patent against its own prior invention. The spokesman is not quoted as addressing the alleged lack of inventive step.

Impossible is appealing against the EPO's decision.

GMWatch will update readers on the reasoning of the EPO, once it is published, and its potential relevance to GMOs that are claimed to be natural or nature-mimicking.





Menu

Home

Subscriptions

News Archive

News Reviews

Videos

Articles

GM Myth Makers

GM Reports

GM Myths

GM Quotes

Non-GM Successes

Contacts

Contact Us

About

Facebook

Twitter

Donations

Content 1999 - 2023 GMWatch.
Web Development By SCS Web Design